D. Western Therapeutics Institute (TSE:4576) YoY EBITDA Growth : 100.00% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is D. Western Therapeutics Institute YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. D. Western Therapeutics Institute's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 100.00%.

D. Western Therapeutics Institute's EBITDA per Share for the three months ended in Dec. 2024 was 円0.00.

D. Western Therapeutics Institute YoY EBITDA Growth Historical Data

The historical data trend for D. Western Therapeutics Institute's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D. Western Therapeutics Institute YoY EBITDA Growth Chart

D. Western Therapeutics Institute Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-245.75

57.64

-251.45

-85.12

-44.00

D. Western Therapeutics Institute Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															-52.31	-78.64	-207.96	-25.08	100.00

D. Western Therapeutics Institute YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

D. Western Therapeutics Institute's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-35.144	-	-24.405)	/	\| -24.405 \|
=	-44.00 %

D. Western Therapeutics Institute's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(0	-	-6.187)	/	\| -6.187 \|
=	100.00 %

D. Western Therapeutics Institute YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

D. Western Therapeutics Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003

Website

http://www.dwti.co.jp

D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

D. Western Therapeutics Institute Headlines

No Headlines